|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.22 HKD | -8.76% |
|
+0.15% | +6.44% |
| 07-16 | Genscript Associate Reports $657 Million in Carvykti Sales Under License Agreement | MT |
| 06-15 | Genscript Associate Reports Promising Phase 1 Data for LB2501 in B-Cell Lymphoma | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -8.76% | +0.15% | +15.16% | -3.85% | +6.44% | -14.04% | -18.90% | -67.20% | +983.61% | 4.05B | |
| -1.29% | -2.54% | +14.85% | +6.81% | +5.58% | -0.35% | +4.30% | -13.76% | +238.18% | 49.7B | |
| +0.13% | -0.86% | +17.44% | +24.66% | +132.62% | +374.47% | +596.28% | +531.49% | - | 38.09B | |
| -1.07% | +4.41% | +18.73% | -3.70% | +2.66% | +7.42% | +57.59% | -2.72% | +985.56% | 35.29B | |
| -1.59% | -0.94% | +20.65% | +16.69% | -8.65% | +26.13% | -6.99% | -14.81% | +184.52% | 35.13B | |
| +0.06% | +1.56% | +0.74% | -11.68% | +1.98% | +4.41% | +27.42% | -20.51% | +149.92% | 27.22B | |
| -4.37% | -3.27% | +13.18% | - | - | - | - | - | - | 16.14B | |
| -4.51% | -0.40% | +17.28% | +2.97% | -4.55% | +67.97% | +116.72% | +203.92% | - | 15.36B | |
| +1.12% | +2.15% | +12.05% | +1.50% | +12.63% | +16.24% | +19.12% | -31.11% | +110.45% | 13.89B | |
| +1.65% | +2.09% | +19.51% | +43.06% | -6.04% | +16.57% | -30.13% | -20.89% | +137.11% | 13.02B | |
| -0.08% | -2.77% | +42.67% | +15.50% | -1.00% | +1,317.36% | +640.37% | +294.05% | +2,672.09% | 11.76B | |
| +2.65% | +0.87% | +30.76% | +21.42% | +22.29% | +34.96% | -13.14% | -36.83% | +157.69% | 11.18B | |
| -1.98% | -4.10% | +22.77% | +21.74% | +12.22% | +42.85% | +6.93% | -40.83% | +162.89% | 11.04B | |
| -0.61% | -9.79% | +7.67% | -5.98% | -11.04% | -13.39% | - | - | - | 9.62B | |
| -11.12% | +0.25% | +51.51% | +45.31% | +77.50% | +243.54% | +544.13% | - | - | 10.05B | |
| -8.08% | +14.53% | +61.35% | +13.03% | +24.80% | +36.83% | +33.12% | -60.05% | - | 9.56B | |
| +5.34% | -3.05% | +28.71% | +31.92% | +48.71% | +149.64% | +412.90% | +110.88% | - | 9.38B | |
| -3.62% | -6.87% | -27.00% | -28.35% | -31.42% | +28.65% | +28.55% | +52.56% | +95.92% | 9.03B | |
| -10.85% | -3.83% | +15.75% | -8.75% | +6.04% | +468.88% | +1,711.86% | +18.86% | - | 8.59B | |
| -6.61% | +7.05% | +26.25% | +32.75% | +61.08% | +149.27% | +566.46% | +201.13% | - | 8.49B | |
| Average | -0.54% | -1.72% | +20.50% | +11.32% | +18.52% | +155.65% | +260.92% | +64.95% | +534.36% | 17.33B | |
| Weighted average by Cap. | -0.35% | -1.36% | +18.55% | +10.46% | +21.94% | +130.02% | +199.31% | +83.50% | +453.39% |
- Stock Market
- Stocks
- 1548 Stock
- Sector Genscript Biotech Corporation
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition